BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23716555)

  • 1. A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.
    Woolthuis CM; Mulder AB; Verkaik-Schakel RN; Rosati S; Diepstra A; van den Berg E; Schuringa JJ; Vellenga E; Kluin PM; Huls G
    Haematologica; 2013 Oct; 98(10):1532-8. PubMed ID: 23716555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.
    Konoplev S; Huang X; Drabkin HA; Koeppen H; Jones D; Kantarjian HM; Garcia-Manero G; Chen W; Medeiros LJ; Bueso-Ramos CE
    Cancer; 2009 Oct; 115(20):4737-44. PubMed ID: 19637342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin mutation analysis in acute myeloid leukaemia: Immunohistochemistry as a surrogate for molecular techniques.
    Chopra A; Soni S; Pati H; Kumar D; Diwedi R; Verma D; Vishwakama G; Bakhshi S; Kumar S; Gogia A; Kumar R
    Indian J Med Res; 2016 Jun; 143(6):763-768. PubMed ID: 27748301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
    Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
    Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surrogate marker to detect nucleophosnim (NPM1) gene mutations in the cytoplasm of acute myeloid leukemia (AML) blast cells in 30 adult Iraqi patients.
    Al-Husseinawi EK
    Ann Saudi Med; 2013; 33(6):539-46. PubMed ID: 24413856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia.
    Quan J; Gao YJ; Yang ZL; Chen H; Xian JR; Zhang SS; Zou Q; Zhang L
    Int J Med Sci; 2015; 12(1):17-22. PubMed ID: 25552914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of cytoplasmic nucleophosmin in formalin-fixed paraffin-embedded marrow trephine biopsies in acute myeloid leukaemia.
    Lit BM; Kwong YL; Wong KF
    J Clin Pathol; 2016 May; 69(5):409-14. PubMed ID: 26500335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an NPM1/MLF1 D-FISH probe set for the detection of t(3;5)(q25;q35) identified in patients with acute myeloid leukemia.
    Aypar U; Knudson RA; Pearce KE; Wiktor AE; Ketterling RP
    J Mol Diagn; 2014 Sep; 16(5):527-532. PubMed ID: 25027285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
    Mattsson G; Turner SH; Cordell J; Ferguson DJ; Schuh A; Grimwade LF; Bench AJ; Weinberg OK; Marafioti T; George TI; Arber DA; Erber WN; Mason DY
    Haematologica; 2010 Apr; 95(4):670-3. PubMed ID: 20015883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations of the nucleophosmin (NPM-1) gene in Egyptian patients with acute myeloid leukemia: a pilot study.
    Kassem N; Hamid AA; Attia T; Baathallah S; Mahmoud S; Moemen E; Safwat E; Khalaf M; Shaker O
    J Egypt Natl Canc Inst; 2011 Jun; 23(2):73-8. PubMed ID: 22099964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
    Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
    N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
    Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
    Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NPMc+ acute myeloid leukemia in bone marrow smears.
    Bedekovics J; Rejtő L; Telek B; Kiss A; Hevessy Z; Ujfalusi A; Méhes G
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):73-8. PubMed ID: 22595947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
    Yoneda-Kato N; Look AT; Kirstein MN; Valentine MB; Raimondi SC; Cohen KJ; Carroll AJ; Morris SW
    Oncogene; 1996 Jan; 12(2):265-75. PubMed ID: 8570204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia.
    Arber DA; Chang KL; Lyda MH; Bedell V; Spielberger R; Slovak ML
    Hum Pathol; 2003 Aug; 34(8):809-13. PubMed ID: 14506644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cytoplasmic nucleophosmin expression by imaging flow cytometry.
    Grimwade L; Gudgin E; Bloxham D; Bottley G; Vassiliou G; Huntly B; Scott MA; Erber WN
    Cytometry A; 2012 Oct; 81(10):896-900. PubMed ID: 22968966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
    Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
    Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
    Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
    Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against nucleophosmin mutants: potentials for the detection of acute myeloid leukemia.
    Tan S; Zhang L; Zhong XM; Yang ZL; Zhao LY; Gao YJ; Shao HY; Qin FX; Chen XC; Zhang HJ; Chen H; Wang L
    Int J Med Sci; 2011; 8(4):309-14. PubMed ID: 21611112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.